Shimotsuke

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Childhood cancers2 trials
• Chronic myeloid leukaemia2 trials
• Diabetic eye disease2 trials
• Multiple sclerosis1 trial

Phase

• Phase 32 trials

Status

• Completed5 trials
• Active, not recruiting2 trials

Lead sponsor

• Novartis Pharmaceuticals7 trials

Running trials

• Active, not recruiting

  Specified Drug-use Surveillance of Fabhalta Capsules

  NCT06606314· Novartis Pharmaceuticals· Source

• Active, not recruiting

  A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP

  NCT04971226· Phase 3· Novartis Pharmaceuticals· Source

Closed trials

• Recruiting

  Special Drug Use-results Surveillance of Tafinlar/Mekinist

  NCT06262919· Novartis Pharmaceuticals· Source

  Contact: Novartis Pharmaceuticals

• Completed

  Special Drug Use Observational Study With Beovu Kit for Intravitreal Injection

  NCT05526729· Novartis Pharmaceuticals· Source

• Completed

  Special Drug Use-results Surveillance of Scemblix Tablets

  NCT05421091· Novartis Pharmaceuticals· Source

• Completed

  Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen

  NCT04940065· Novartis Pharmaceuticals· Source

• Completed

  Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy

  NCT04278417· Phase 3· Novartis Pharmaceuticals· Source